Efficacy of Bacillus clausii UBBC-07 and Bacillus coagulans Unique IS-2 in Mitigating Pulmonary Parameters in Patients With Moderate COVID-19 Symptoms.
- 2024-12-26
- RCT · n = 56
- Cureus 16(12)
- Mehdi Ali Mirza
- Rajiv Kumar Bandaru
- Ushasree T
- PubMed: 39866999
- DOI: 10.7759/cureus.76436
- High evidence
No significant differences were observed in other biomarkers, including CRP, LDH, and interleukin-6.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 2 billion spores, twice daily for 14 days